EUVIMEDEUVIMED entdecken
Crossref

Plasma neutrophil gelatinase-associated lipocalin level as a predictor of atherosclerotic cardiovascular disease risk in patients undergoing catheterization

Fadia Mayyas

Microvascular Research · 2025

DOI: 10.1016/j.mvr.2025.104797 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microvascular Research, 2025. Verfasst von Fadia Mayyas. Beteiligte Einrichtung: Department of Clinical Pharmacy, Faculty of Pharmacy, Jordan University of Science and Technology, 3030, Irbid 22110, Jordan. Electronic address: fam…. Hauptthemen laut MEDLINE: Lipocalin-2, Coronary Artery Disease, Cardiac Catheterization, Acute Coronary Syndrome. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: Jordan University of Science and Technology, Deanship of Scientific Research, University of Jordan, Jordan University of Science and Technology Deanship of Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Atherosclerotic cardiovascular diseases (ASCVDs) represent a global health burden contributing to substantial morbidity and mortality. The neutrophil gelatinase-associated lipocalin (NGAL), a small glycoprotein, is secreted by inflammatory neutrophils, macrophages, and dendritic cells, playing a role in inflammation. However, its relevance as a predictor of ASCVDs risk across patients from low to very high-risk, and correlation with the need for revascularization by percutaneous coronary intervention (PCI) or coronary artery bypass surgery (CABG) remains largely unexplored. Our objective was to assess plasma NGAl levels in patients with low to very high risk of ASCVD and their relationship with the severity of CAD and the requirement for revascularization. METHODS: Outpatients and patients undergoing catheterization were categorized into low, moderate, high, and very high risk of ASCVD. Plasma levels of NGAL were measured using ELISA and analyzed in relation to CAD status and the need for revascularization by PCI or CABG. RESULTS: Plasma NGAl levels were elevated in CAD patients, with higher levels in patients with acute coronary syndrome compared to those with stable angina. A gradual increase in plasma NGAl levels was noted with the elevated risk of ASCVD and degree of coronary artery stenosis. Notably, plasma NGAl level was independently correlated with ASCVD risk and the need for revascularization by PCI. CONCLUSION: Our study indicates that plasma NGAl levels are linked to the risk of ASCVD and may help predict the development and severity of CAD. Further research targeting NGAL could explore its potential to mitigate the risk of ASCVD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lipocalin-2Coronary Artery DiseaseCardiac CatheterizationAcute Coronary SyndromeAngina, StableCoronary StenosisAtherosclerosisHumansMaleFemaleAgedMiddle AgedBiomarkersPredictive Value of TestsRisk AssessmentPercutaneous Coronary InterventionSeverity of Illness IndexCoronary Artery BypassRisk FactorsUp-RegulationPrognosis

Stichwörter der Autor:innen

Atherosclerotic cardiovascular disease riskCoronary artery bypass surgeryCoronary artery diseaseNeutrophil gelatinase-associated lipocalinPercutaneous coronary intervention

Substanzen

Lipocalin-2LCN2 protein, humanBiomarkers

Autor:innen und Institutionen

  • Department of Clinical Pharmacy, Faculty of Pharmacy, Jordan University of Science and Technology, 3030, Irbid 22110, Jordan. Electronic address: famayyas@just.edu.jo.

Förderung

  • Jordan University of Science and Technology
  • Deanship of Scientific Research, University of Jordan
  • Jordan University of Science and Technology Deanship of Research

Zitieren

APA

Mayyas, F. (2025). Plasma neutrophil gelatinase-associated lipocalin level as a predictor of atherosclerotic cardiovascular disease risk in patients undergoing catheterization. Microvascular Research. https://doi.org/10.1016/j.mvr.2025.104797

Vancouver

Mayyas F. Plasma neutrophil gelatinase-associated lipocalin level as a predictor of atherosclerotic cardiovascular disease risk in patients undergoing catheterization. Microvascular Research. 2025. doi:10.1016/j.mvr.2025.104797

BibTeX
@article{Mayyas2025,
  author = {Mayyas, Fadia},
  title = {Plasma neutrophil gelatinase-associated lipocalin level as a predictor of atherosclerotic cardiovascular disease risk in patients undergoing catheterization},
  journal = {Microvascular Research},
  year = {2025},
  doi = {10.1016/j.mvr.2025.104797}
}
Kostenlos starten →